Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath Publishes Summer 2026 Issue of Alumni Journal

Read More

News & Insights

Home Depot’s $14.5 Billion of Revolving Credit Facilities in Connection with the Pending Acquisition of SRS Distributions Inc.

May 21, 2024

Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with $14.5 billion of credit facilities made available to The Home Depot, Inc., the world’s largest home improvement retailer, as part of the financing transactions undertaken in connection with the pending acquisition of SRS Distribution Inc. The facilities consisted of a $10 billion revolving credit facility, $3.5 billion 364‑day revolving credit facility and $1.0 billion three‑year revolving credit facility. The transaction closed on May 7, 2024.

The Cravath team included partner Tatiana Lapushchik and associates Julia Nagle and Hannah Gehringer on banking matters, associate Eduardo D. Jacobo on tax matters, and practice area attorney David Crampton and associate Jonathan C. Nickas on executive compensation and benefits matters.

Related Practices & Industries

  • Corporate
  • Banking and Credit
  • Tax
  • Executive Compensation and Benefits
  • Consumer Products and Services
  • Retail

People

Photo
Name
Tatiana Lapushchik
Title
Corporate
Title
Partner
Email
tlapushchik@cravath.com
Phone
+1-212-474-1442
vCard
Download vCard

    Education

    • J.D., 2000, Harvard Law School
      cum laude
    • B.A., 1997, Barnard College
      summa cum laude

    Admitted In

    • New York

    Related News & Insights

    Deals & Cases

    July 06, 2026

    UVEX’s Upsize and Repricing of its Term Loan Facility

    Cravath represented the agent, mandated lead arrangers, and lenders in connection with the repricing of UVEX GROUP GmbH’s €400 million term loan facility and €50 million term loan add-on. UVEX GROUP GmbH is a portfolio company of Warburg Pincus. The transaction closed on June 19, 2026. 

    Deals & Cases

    April 06, 2026

    Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent

    Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.

    Deals & Cases

    February 20, 2026

    First Solar’s $1.5 Billion Revolving Credit Facility

    Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.

    Deals & Cases

    January 08, 2026

    Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus

    Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.

    Cravath Bicentennial

    Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

    Explore

    Cravath, Swaine & Moore LLP Logo
    • CONTACT US
    • OUR STORY
    • ALUMNI PORTAL
    • DISCLAIMERS & NOTICES

    Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.